Literature DB >> 12523627

Clonal and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) from a Portuguese hospital over time.

M L Amorim1, M Aires de Sousa, I Santos Sanches, R Sá-Leão, J M Cabeda, J M Amorim, H de Lencastre.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered from a general hospital in Oporto, Portugal, during two periods (1992-1993 and 1996-2000) were characterized by pulsed-field gel electrophoresis (PFGE) of SmaI fragments, and by hybridization of ClaI digests with mecA and Tn554 probes, discriminating the isolates in mecA::Tn554::PFGE genotypes. In addition, a representative sample of the defined genotypes was characterized by multilocus sequence typing (MLST) and SCCmec (staphylococcal cassette chromosome mec) typing, generating the corresponding ST-SCCmec types. In 1992-1993, 77% of MRSA belonged to the Iberian clone (genotype I::E::A or ST247-IA). In 1996-2000, the frequency of this clone decreased to 19% and the majority (69%) of the isolates belonged to another international clone, the Brazilian MRSA (genotype XI::B::B or ST239-IIIA). Trimethoprim/sulfamethoxazole (SXT) was confirmed to be an important phenotypic marker to distinguish the Iberian (SXT-susceptible) and the Brazilian (SXT-resistant) clones in MRSA isolates from Portugal. Our observations document major shifts in the dominant MRSA clonal types that occurred in this hospital since 1992, suggesting a selective advantage of the Brazilian relatively to the Iberian clone. In addition to these two MRSA clones that are the most frequent in Portuguese hospitals since the early 1990s, sporadic MRSA clones (representing 14% of the total) were identified and characterized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12523627     DOI: 10.1089/10766290260469561

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  17 in total

1.  Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic.

Authors:  O Melter; M Aires de Sousa; P Urbásková; V Jakubů; H Zemlicková; H de Lencastre
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA.

Authors:  M Aires de Sousa; H de Lencastre
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  Tracking methicillin-resistant Staphylococcus aureus clones during a 5-year period (1998 to 2002) in a Spanish hospital.

Authors:  Eduardo Pérez-Roth; Fabián Lorenzo-Díaz; Ninivé Batista; Antonio Moreno; Sebastián Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

4.  Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period.

Authors:  D S Blanc; C Petignat; A Wenger; G Kuhn; Y Vallet; D Fracheboud; S Trachsel; M Reymond; N Troillet; H H Siegrist; S Oeuvray; M Bes; J Etienne; J Bille; P Francioli; G Zanetti
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

5.  Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital.

Authors:  M L Amorim; N A Faria; D C Oliveira; C Vasconcelos; J C Cabeda; A C Mendes; E Calado; A P Castro; M H Ramos; J M Amorim; H de Lencastre
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

6.  Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007.

Authors:  Olivier Dauwalder; Gérard Lina; Géraldine Durand; Michèle Bes; Hélène Meugnier; Vincent Jarlier; Bruno Coignard; François Vandenesch; Jerome Etienne; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2008-07-30       Impact factor: 5.948

7.  Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Davida S Smyth; Bo Shopsin; David J Farrell; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

8.  Prevalence and molecular epidemiology of methicillin-resistant Staphylococcus aureus in a tertiary Greek hospital.

Authors:  M Kachrimanidou; E Tsorlini; E Katsifa; S Vlachou; S Kyriakidou; K Xanthopoulou; K Tsergouli; T Samourli; A Papa
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

9.  Evolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina.

Authors:  Claudia Sola; Paulo Cortes; Hector A Saka; Ana Vindel; José Luis Bocco
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

10.  Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy.

Authors:  Floriana Campanile; Dafne Bongiorno; Sonia Borbone; Stefania Stefani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-06-24       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.